1.4660
-0.0300
(-2.01%)
At close: January 23 at 9:04:17 PM GMT+1
Loading Chart for 0OG0.SG
DELL
- Previous Close
1.4960 - Open
1.4680 - Bid 1.4760 x --
- Ask 1.5100 x --
- Day's Range
1.4660 - 1.4880 - 52 Week Range
1.1820 - 2.6200 - Volume
0 - Avg. Volume
536 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 11, 2025 - Feb 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 0OG0.SG
View MorePerformance Overview: 0OG0.SG
Trailing total returns as of 1/23/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
0OG0.SG
2.66%
S&P/TSX Composite index
3.30%
1-Year Return
0OG0.SG
12.74%
S&P/TSX Composite index
21.55%
3-Year Return
0OG0.SG
71.57%
S&P/TSX Composite index
23.34%
5-Year Return
0OG0.SG
86.06%
S&P/TSX Composite index
44.51%
Compare To: 0OG0.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.4660
-2.01%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.40
+9.76%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
6.69
-3.74%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.1250
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.3300
0.00%
Mkt Cap EUR 119.978M
Industry Drug Manufacturers—Specialty & Generic
6.79
-2.86%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
6.73
-2.75%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.8270
-0.44%
Mkt Cap EUR 249.977M
Industry Drug Manufacturers—Specialty & Generic
4.6940
-0.76%
Mkt Cap EUR 890.513M
Industry Drug Manufacturers—Specialty & Generic
0.3340
-2.91%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 0OG0.SG
View MoreValuation Measures
As of 1/22/2025
Market Cap
189.75M
Enterprise Value
120.32M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.33
Price/Book (mrq)
0.92
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--